Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs

对SARS-CoV-2 HLA-I肽组进行分析,揭示了来自移码开放阅读框的T细胞表位

阅读:3
作者:Shira Weingarten-Gabbay,Susan Klaeger,Siranush Sarkizova,Leah R Pearlman,Da-Yuan Chen,Kathleen M E Gallagher,Matthew R Bauer,Hannah B Taylor,W Augustine Dunn,Christina Tarr,John Sidney,Suzanna Rachimi,Hasahn L Conway,Katelin Katsis,Yuntong Wang,Del Leistritz-Edwards,Melissa R Durkin,Christopher H Tomkins-Tinch,Yaara Finkel,Aharon Nachshon,Matteo Gentili,Keith D Rivera,Isabel P Carulli,Vipheaviny A Chea,Abishek Chandrashekar,Cansu Cimen Bozkus,Mary Carrington  ; MGH COVID- Collection & Processing Team  ; Nina Bhardwaj,Dan H Barouch,Alessandro Sette,Marcela V Maus,Charles M Rice,Karl R Clauser,Derin B Keskin,Daniel C Pregibon,Nir Hacohen,Steven A Carr,Jennifer G Abelin,Mohsan Saeed,Pardis C Sabeti

Abstract

T cell-mediated immunity plays an important role in controlling SARS-CoV-2 infection, but the repertoire of naturally processed and presented viral epitopes on class I human leukocyte antigen (HLA-I) remains uncharacterized. Here, we report the first HLA-I immunopeptidome of SARS-CoV-2 in two cell lines at different times post infection using mass spectrometry. We found HLA-I peptides derived not only from canonical open reading frames (ORFs) but also from internal out-of-frame ORFs in spike and nucleocapsid not captured by current vaccines. Some peptides from out-of-frame ORFs elicited T cell responses in a humanized mouse model and individuals with COVID-19 that exceeded responses to canonical peptides, including some of the strongest epitopes reported to date. Whole-proteome analysis of infected cells revealed that early expressed viral proteins contribute more to HLA-I presentation and immunogenicity. These biological insights, as well as the discovery of out-of-frame ORF epitopes, will facilitate selection of peptides for immune monitoring and vaccine development.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。